AI-supported mammography screening reduces advanced breast cancer rates and improves early detection, according to the largest randomized controlled trial to date.
Key Details
- 1Over 100,000 Swedish women were randomized to AI-supported vs. standard double-reading mammography screening.
- 2AI-supported screening resulted in a 12% reduction in interval (between-screening) breast cancer diagnoses.
- 316% fewer invasive, 21% fewer large, and 27% fewer aggressive subtype cancers were identified in the AI arm.
- 481% of cancers were detected at screening with AI, versus 74% in the control group—a 9% increase.
- 5False positive rates were similar between groups (1.5% AI, 1.4% control), and radiologist workload was reduced by 44% in interim analyses.
- 6The study supports use of tested AI tools as an aid—not a replacement—for radiologists, especially amid workforce shortages.
Why It Matters
This landmark trial shows substantial clinical benefit and workflow relief from using AI in breast cancer screening, supporting adoption in radiology programs facing growing patient volumes and staff shortages. The findings may shape future screening guidelines and training requirements for imaging AI use.
Source
EurekAlert
Related News
•EurekAlert
Peking University Debuts LargePNet for Superior Fluorescence Image Restoration
Peking University's Xi Peng lab introduces LargePNet, a new AI for robust fluorescence image restoration, outperforming patch-based methods.
•EurekAlert
Broadband Optical Spectroscopy Enables Early NEC Detection in Preemies
Researchers successfully used a noninvasive broadband optical spectroscopy (BOS) device to detect necrotizing enterocolitis (NEC) early in premature infants.
•EurekAlert
AI Predicts Brain Tumor Risks from Routine Pathology Slides
Mayo Clinic developed an AI that analyzes routine pathology slides to classify meningiomas and predict recurrence risk, reducing dependency on advanced genetic testing.